Multiple bacterial macromolecular and enzymatic targets

Multiple bacterial macromolecular and enzymatic targets is a collective designation used to describe the site of action for antimicrobial agents that do not bind to a single specific receptor but instead interact with various bacterial components (ChEMBL, 2024). This classification encompasses essential bacterial enzymes, structural proteins, and nucleic acids that are critical for cellular viability and replication (NCBI, 2023). Agents such as silver sulfadiazine, chlorhexidine, and povidone-iodine fall into this category because they exert their effects through non-specific mechanisms, including the disruption of cell membranes and the denaturation of cytoplasmic proteins (StatPearls, 2023). By targeting multiple pathways simultaneously, these drugs provide broad-spectrum activity and are generally less susceptible to the rapid development of high-level resistance compared to single-target antibiotics (PubMed, 2022). However, this lack of specificity can lead to therapeutic challenges, such as potential toxicity to host tissues or the unintended destruction of beneficial commensal bacteria (NIH, 2021).

Other names

Bacterial macromolecular targetsMulti-target bacterial componentsNon-specific bacterial targets

Non-specific disruption of bacterial cell membranes, denaturation of intracellular proteins, and simultaneous interference with multiple enzymatic pathways and nucleic acid synthesis.